Tag:
escallantide
Latest Headlines
Latest Headlines
Cubist shelves ecallantide program
Cubist Pharmaceuticals is shelving its program for ecallantide, a once promising therapy for reducing blood loss in surgery, and axing its development deal on the drug with Dyax. The troubled program
